LI An-na. The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
|
Citation:
|
LI An-na. The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
|
LI An-na. The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
|
Citation:
|
LI An-na. The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
|
DownLoad: